Stock Analiz

Insulet Corp. (PODD) stock forecast and price target

Price $152.48 · data as of November 13, 2026

12-month price target

Average target$178.57
Upside / downside+17.1%
Analysts23
ConsensusBuy
Low $160.00Average $178.57High $200.00

Gold marker: average target · white marker: today’s price ($152.48)

Analyst ratings

Strong buy 4Buy 11Hold 11Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$6.77+36.3%$3.3B
Next fiscal year
ends December 31, 2027
$7.91+16.8%$3.7B
Next quarter
ends December 31, 2026
$1.75+13.1%$900M
Quarter after
ends March 31, 2027
$1.66+16.7%$851M

Consensus of the analysts covering Insulet, updated daily. In the last 30 days 16 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 17.1% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Insulet’s intrinsic value about 47% below today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Insulet stock price target?

The average 12-month target from 23 analysts is $178.57, 17.1% above the current price of $152.48 Targets range from $160.00 to $200.00.

Is Insulet a buy according to analysts?

The consensus rating is “Buy” (4 strong buy, 11 buy, 11 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Insulet expected to earn?

Analysts expect EPS of $6.77 for the fiscal year ending December 31, 2026 and $7.91 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.